Clinicopathological Characteristics and Prognostic Value of the Cancer Stem Cell Marker ALDH1 in Ovarian Cancer: A Meta-Analysis

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s160207
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Prognostic Value of ALDH1 and Nestin in Advanced Cancer: A Systematic Meta-Analysis With Trial Sequential Analysis

Therapeutic Advances in Medical Oncology
Oncology
2019English

Prognostic and Clinicopathological Value of GATA Binding Protein 3 in Breast Cancer: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2017English

Clinicopathological and Prognostic Significance of HMGA2 Overexpression in Gastric Cancer: A Meta-Analysis

Oncotarget
Oncology
2017English

The Prognostic Value of P16 Hypermethylation in Cancer: A Meta-Analysis

PLoS ONE
Multidisciplinary
2013English

Clinical Value of lncRNA MALAT1 as a Prognostic Marker in Human Cancer: Systematic Review and Meta-Analysis

BMJ Open
Medicine
2015English

Prognostic Value and Clinicopathological Significance of Serum- And Tissue-Based Cytokeratin 18 Express Level in Breast Cancer: A Meta-Analysis

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2018English

Comprehensive Analysis of Expression and Prognostic Value of Sirtuins in Ovarian Cancer

Frontiers in Genetics
GeneticsMolecular Medicine
2019English

Prognostic and Clinicopathological Significance of PD-L1 in Patients With Bladder Cancer: A Meta-Analysis

Frontiers in Pharmacology
Pharmacology
2019English

Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy